[HTML][HTML] Current and future biomarkers in colorectal cancer
G Zarkavelis, S Boussios, A Papadaki… - Annals of …, 2017 - ncbi.nlm.nih.gov
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
Current and future biomarkers in colorectal cancer.
G Zarkavelis, S Boussios, A Papadaki… - Annals of …, 2017 - search.ebscohost.com
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
Current and future biomarkers in colorectal cancer
G Zarkavelis, S Boussios, A Papadaki… - Annals of …, 2017 - annalsgastro.gr
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
Current and future biomarkers in colorectal cancer
G Zarkavelis, S Boussios… - Annals of …, 2017 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
[引用][C] Current and future biomarkers in colorectal cancer
G Zarkavelis - Annals of Gastroenterology, 2017 - cir.nii.ac.jp
Current and future biomarkers in colorectal cancer | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF][PDF] Current and future biomarkers in colorectal cancer
G Zarkavelisa, S Boussiosa, A Papadakia… - Annals of …, 2017 - researchgate.net
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
[PDF][PDF] Current and future biomarkers in colorectal cancer
G Zarkavelisa, S Boussiosa… - Annals of …, 2017 - pdfs.semanticscholar.org
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
Current and future biomarkers in colorectal cancer.
G Zarkavelis, S Boussios, A Papadaki… - Annals of …, 2017 - europepmc.org
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
Current and future biomarkers in colorectal cancer
G Zarkavelis, S Boussios, A Papadaki… - Annals of …, 2017 - annalsgastro.gr
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
Current and future biomarkers in colorectal cancer
G Zarkavelis, S Boussios, A Papadaki… - Annals of …, 2017 - 172.104.143.169
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …
heterogeneous disease and is characterized by diversions in multiple molecular pathways …